Inquis Medical is a privately funded medical device company dedicated to advancing the treatment of venous thromboembolic diseases with innovative patient-centric technologies
Inquis Medical was founded in Silicon Valley in 2020 by seasoned entrepreneurs with decades of experience. The team has spent years developing, launching and supporting novel, physician tested technologies addressing unmet needs with a long lasting impact.
Inquis Medical is dedicated to transforming the treatment of venous thromboembolism (VTE) with advanced, patient-centric solutions.
Our innovative technology for TrueClotâ„¢ sensing, efficient extraction and streamlined blood return is designed to improve ease of use, reduce procedure times and minimize blood loss.
AVENTUS Thrombectomy System
Indications for Use: The AVENTUS Thrombectomy System is indicated for:
The AVENTUS Thrombectomy System is intended for use in the peripheral vasculature.
The AVENTUS Clot Management System is indicated for use with the AVENTUS Thrombectomy System for autologous blood transfusion.
AVENTUS Thrombectomy System
Indications for Use: The AVENTUS Thrombectomy System is indicated for:
The AVENTUS Thrombectomy System is intended for use in the peripheral vasculature.
The AVENTUS Clot Management System is indicated for use with the AVENTUS Thrombectomy System for autologous blood transfusion.